Media

For media inquiries, please contact: media@canntrust.ca

RECENT PRESS RELEASES

CannTrust Discloses Notice of Licence Suspension

VAUGHAN, ON, Sept. 17, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) announced that it received late this morning a Notice of Licence Suspension (the "Notice") under section 64(1) of the Cannabis Act (Canada). The Notice...

CannTrust Provides Default Status Report

VAUGHAN, ON, Sept. 12, 2019 /CNW/ – CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CannTrust Provides Default Status Report

VAUGHAN, ON, Aug. 29, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CANNTRUST

Since 2013, CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories: the adult use market, over-the-counter, natural healthcare products, pet care, and beauty.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest